Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 2Rectal Neoplasms 1Prostatic Neoplasms 1Osteoarthritis 1Glioma 1Colorectal Neoplasms 1Colonic Neoplasms 1Cancer Pain 1Brain Stem Neoplasms 1Brain Neoplasms 1Barrett Esophagus 1Advanced Non-small Cell Lung Cancer 1Adenomatous Polyposis Coli 1

Interventions

Endoscopy 13Endoscopy, Digestive System 12Radiofrequency Ablation 7Esomeprazole 7Biopsy 7Endoscopic Mucosal Resection 6Specimen Handling 4Proflavine 4Omeprazole 4Aspirin 4Gastroscopy 3YF 476 2Proton Pump Inhibitors 2Photochemotherapy 2Narrow Band Imaging 2Microscopy, Confocal 2Metformin 2Lansoprazole 2Itraconazole 2Endoscopes 2Diagnostic Imaging 2Dexlansoprazole 2Cryotherapy 2Cryosurgery 2Breath Tests 22-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2rofecoxib 1polyphenon E 1plecanatide 1omeprazole, sodium bicarbonate drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Barrett Esophagus × rofecoxib × Clear all
NCT00637988 2011-01-21

Barrett's Esophagus - 315 - 3 Way Cross Over

AstraZeneca

Phase 4 Completed
32 enrolled
Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡